HomeNewsTechnologyXiaomi increases prices of Redmi Note 8, Redmi 8 and Redmi 8A Dual in India

Xiaomi increases prices of Redmi Note 8, Redmi 8 and Redmi 8A Dual in India

The new price hikes are quite substantial for entry-level devices but seem unavoidable given the current circumstances.

May 14, 2020 / 18:30 IST
Story continues below Advertisement

Xiaomi has made its way to the top of India’s smartphone market with strong offerings in the country’s budget segment. However, the recent GST hike saw prices of the company’s budget Redmi phones go up. Now, it looks like some entry-level Redmi phones have received yet another price hike.

According to a Gadget360 report, Xiaomi increased the prices of the Redmi Note 8 by Rs 500 and the cost of the Redmi 8 and 8A Dual by Rs 300 each. The Redmi Note 8 (4GB/64GB) now costs Rs 11,499 rather than Rs 10,999, while the 6GB/128GB Note 8 remains the same at Rs 13,999. Over the course of two months, the price of the Redmi Note 8 has gone up by Rs 1,500.

Story continues below Advertisement

The Redmi 8 (4GB/64GB) now costs Rs 9,299, up from Rs 8,999, while the Redmi 8A Dual (2GB/32GB) is now available for Rs 7,299, previously Rs 6,999, The Redmi 8 launched at Rs 6,999, while the Redmi 8A Dual featured a Rs 6,499 launch price.

The GST price hike was directly responsible for the previous price hike, but Xiaomi has not confirmed the reason for the second price increase. However, it can be also be attributed to the coronavirus pandemic, which saw Indian smartphones sales slump to zero in the month of April.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show